Developments in the use of drugs to improve reproduction and embryo product
ion have focused on estrus and ovulation synchronization protocols and embr
yonic survival. Protocols for synchronization of ovulation eliminate the ne
ed for detection of estrus and allow timed insemination of all cows enrolle
d. Various estrogenic, progestational, GnRH and PGF(2 alpha)-like drugs are
used to synchronize follicle development, CL regression and induction of o
vulation. Strategies are discussed to optimize such programs to maximize he
rd pregnancy rates. Use of bovine Somatotrophin (bST) in combination with t
he Ovsynch protocol resulted in increased pregnancy rates, indicating possi
ble effects on oocyte and embryonic development. Treatment of embryo donor
cows with bST reduced the proportion of unfertilized oocytes and increased
the number of transferable embryos. Furthermore, bST increased pregnancy ra
te when given to the recipient. Sub-luteal plasma progesterone concentratio
ns after insemination have been associated with lower pregnancy rates. Inje
ction of hCG on day 5 post-insemination resulted in induction of an accesso
ry CL, increased plasma progesterone concentrations and increased conceptio
n rates. Strategies involving the use of sustained GnRH agonists to enhance
CL development and alter follicular development are considered for future
programs to enhance pregnancy rates. (C) 2000 by Elsevier Science inc.